Author： Haas Jennifer S. Amato Mary Marinacci Lucas Orav E. John Schiff Gordon D. Bates David W.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.35, Iss.8, 2012-08, pp. : 623-628
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmaceutical Reference Prices: How do They Work in Practice?
By Dickson M.
PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. :
Access to resources
Recommend
Do physicians consider cost effectiveness in clinical practice?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. :
Resistance to antibacterial prescribing practice?
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :
What do Stakeholders Think about Pharmacovigilance?
Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. :
Warfarin in AF: effective in clinical practice?
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :